PepDiana
Back to Evidence
Primary experimental recordPositive observation

PMC11904594::ACT012984

BP76

Evidence text

Paper-level observation

Section 3.1: five out of 26 compounds reduced at least 88% of growth in P. aeruginosa strains
textConfidence: medium

Assay observation

Activity
Antimicrobial
Subtype
Antibacterial
Measure
percent_inhibition
Comparator
=
Raw observation
≥88%
Normalized measurement
=88%
Value minimum
Not reported by source
Value maximum
Not reported by source
Target
Pseudomonas aeruginosa
Assay method
Not reported by source
Sequence
KKLFKKILKFLNH
Standardization
ready simple

Source publication

Identification and characterization of amphipathic antimicrobial peptides with broad spectrum activity against multi-drug resistant bacteria.

Current Research in Microbial Sciences · 2025

DOI 10.1016/j.crmicr.2025.100363 PMC11904594
Parent mention

Related peptide identities

PEPDIA-PLP-001503

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.